Font Size: a A A
Keyword [Ischemic Cardiomyopathy]
Result: 121 - 140 | Page: 7 of 8
121. Clinical Features And Prognostic Factors Of Patients With Ischemic Cardiomyopathy
122. Mining Of Hub Immune-related LncRNAs In Coronary Artery Disease And Multi-omics Integration Analysis Of Characteristics Of Immune Molecules In Ischemic Cardiomyopathy
123. ST2 Evaluation Of Cardiac Function Parameters Of Sacubitril/Valsartan In Ischemic Cardiomyopathy
124. Clinical And Basic Study Of Abnormal Myocardial Glucose Metabolism Based On 18F-FDG PET Myocaidial Metabolic Imaging In Diabetes
125. Correlation Study Between Mfn2 Gene And Susceptibility As Well As Prognosis Of Ischemic Cardiomyopathy
126. Study On Broad-spectrum Anti-ischemia Mechanism Of Geshitongmai Granule In The Treatment Of Ischemic Cardiomyopathy
127. The SIRT1-SIRT3 Axis Protects Cardiomyocytes Against Myocardial Ischemia-reperfusion Injury By Regulating Mitophagy-related Ferroptosis Via The PINK1/Parkin Signaling Pathway
128. The Role Of CD163 On Ventricular Remodeling In Mice With Ischemic Cardiomyopathy
129. Clinical Characteristics And Prognosis Of Patients With Ischemic Cardiomyopathy Combined With Heart Failure With Improved Ejection Fraction
130. Diagnostic Value Of Electrocardiogram In Infarction-related Artery Location And Ischemic Cardiomyopathy In Patients With St-segment Elevation Myocardial Infarction
131. Analysis Of Prognostic Factors Of Cardiopulmonary Bypass-assisted Coronary Artery Bypass Grafting In Ischemic Cardiomyopathy
132. Screening Of Biomarkers For Ischemic Cardiomyopathy And Analysis Of Tanshinone ⅡA Drug Targets Based On Data Mining
133. Diagnostic Significance And Prognosis Prediction Of Electrocardiogram Plane QRS-T Angle In Patients With Non-ST Segment Elevation Acute Coronary Syndrom
134. Construction Of A Predictive Model For Early Adverse Prognosis Of Ischemic Cardiomyopathy And Analysis Of Prognostic Factors For Dapagliflozin Therapy
135. Evaluation Of Viable Myocardium In Patients With Ischemic Cardiomyopathy By SPECT/CT Imaging
136. Clinical Observation Of Intermittently Repeated Application Of Levosimendan For Ischemic Cardiomyopathy
137. A Meta-analysis Of The Efficacy And Safety Of Nicorandil In Patie Nts With Ischemic Cardiomyopathy And Heart Failure
138. Development And Validation Of A Predictive Model Of The Impac Of Single Nucleotide Polymorphisms In The ICAM-1 Gene On The Risk Of Ischemic Cardiomyopathy
139. Correlation Study Of Intercellular Adhesion Molecule-1 Gene PolymorPhisms With Susceptibility And Prognosis Of Ischemic Cardiomyopathy
140. Neutrophil-Lymphocyte Ratio As A Predictor Of Prognosis In Ischemic Cardiomyopathy
  <<First  <Prev  Next>  Last>>  Jump to